Latest News about ATAI
Recent news which mentions ATAI
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
July 30, 2025
From Benzinga
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
July 29, 2025
From Benzinga
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
July 28, 2025
From Benzinga
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 28, 2025
From Benzinga
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus
July 28, 2025
From Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
July 28, 2025
From Benzinga
From Benzinga
From Benzinga
Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday
July 01, 2025
From Benzinga
Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data
July 01, 2025
From Benzinga
CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 04, 2025
From Benzinga
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
From Benzinga
Trade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 13, 2025
From Benzinga
Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
February 13, 2025
From Benzinga
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
From Benzinga
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
From Benzinga
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
From Benzinga
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
August 13, 2024
Tickers
ATAI
From InvestorPlace
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
From Benzinga
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
From InvestorPlace
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
July 08, 2024
From InvestorPlace
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
From InvestorPlace
From InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.